News
Issued by Enlaza Therapeutics, not Vertex Pharmaceuticals Incorporated
Enlaza Therapeutics Announces Strategic Collaboration with Vertex Pharmaceuticals to Develop War-Lock Drug Conjugates and T-Cell Engagers for Improved Conditioning and Certain Autoimmune Diseases
September 2, 2025 · View original source (Business Wire)
It isn’t one of Vertex Pharmaceuticals Incorporated’s news releases, so 6ix doesn’t show it on Vertex Pharmaceuticals Incorporated’s page or send it as an alert.